Medicamen Biotech share price
You have to be logged in to add this to Watchlist.Medicamen Biotech is trading -1.19% lower at Rs 442.70 as compared to its last closing price. Medicamen Biotech has been trading in the price range of 456.85 & 434.70. Medicamen Biotech has given -25.93% in this year & -1.15% in the last 5 days.
Medicamen Biotech has TTM P/E ratio 80.09 as compared to the sector P/E of 33.29.
The company posted a net profit of 1.46 Crores in its last quarter.
Listed peers of Medicamen Biotech include Wanbury (1.99%), Titan Biotech (3.16%), Medicamen Biotech (-1.19%) etc.
Medicamen Biotech has a 57.01% public holding. The FII holding in Medicamen Biotech was at 0.06% in 30 Sep 2024. The FII holding has decreased from the last quarter.
Medicamen Biotech share price range
|
| ||||
|
| ||||
Medicamen Biotech share Key Metrics
| Market Cap ( ₹ Cr.) | 568.02 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Medicamen Biotech Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 14-Nov-24 | Quarterly Results |
| 13-Aug-24 | Quarterly Results |
| 29-May-24 | Audited Results & Final Dividend |
| 12-Feb-24 | Quarterly Results |
| 10-Nov-23 | Quarterly Results |
| 08-Aug-23 | Quarterly Results |
| 29-May-23 | Audited Results & Final Dividend |
| 10-Feb-23 | Quarterly Results |
| 11-Nov-22 | Quarterly Results |
| 10-Aug-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 25-Sep-24 | 16-Aug-24 | AGM |
| 27-Sep-23 | 11-Aug-23 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 29-May-24 | - | 19-Sep-24 | 1 |
| 11-Aug-23 | - | 20-Sep-23 | 1 |
| 28-Jun-21 | - | 16-Sep-21 | 1 |
FAQs about Medicamen Biotech share price
Medicamen Biotech is trading at 442.70 as on Mon Nov 25 2024 09:58:51. This is -1.19% lower as compared to its previous closing price of 448.05.
The market capitalization of Medicamen Biotech is 568.02 Cr as on Mon Nov 25 2024 09:58:51.
The 52 wk high for Medicamen Biotech is 661.85 whereas the 52 wk low is 356.75
Medicamen Biotech can be analyzed on the following key metrics -
- TTM P/E: 80.09
- Sector P/E: 33.29
- Dividend Yield: 0.22%
- D/E ratio: 0.09
Medicamen Biotech reported a net profit of 10.93 Cr in 2024.
Medicamen Biotech Quick Links
Medicamen Biotech Dividend Medicamen Biotech Bonus Medicamen Biotech News Medicamen Biotech AGM Medicamen Biotech Rights Medicamen Biotech Splits Medicamen Biotech Board Meetings Medicamen Biotech Key Metrics Medicamen Biotech Shareholdings Medicamen Biotech Profit Loss Medicamen Biotech Balance Sheet Medicamen Biotech Cashflow Medicamen Biotech Q1 Results Medicamen Biotech Q2 Results Medicamen Biotech Q3 Results Medicamen Biotech Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks